Advertisement

Topics

Nasal Glucagon Fixes Severe Hypoglycemia in Type 1 Diabetes

06:45 EDT 29 Jun 2017 | Medscape

Lilly plans to submit a US new drug application for the product in 2018 as a "real-world" study demonstrates efficacy.
Medscape Medical News

Original Article: Nasal Glucagon Fixes Severe Hypoglycemia in Type 1 Diabetes

NEXT ARTICLE

More From BioPortfolio on "Nasal Glucagon Fixes Severe Hypoglycemia in Type 1 Diabetes"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Lilly
Eli Lilly and Company was founded in 1876, and is now the 9th largest pharmaceutical company based an annual sales which were just under $20bn in 2009. Orginally from the USA, Lilly now operates in over 50 countries with just under 40,000 employees. Appr...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...